Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Flonoltinib maleate - Chengdu Zenitar Biomedical Technology

Next Previous
X
Search
Drug Profile

Flonoltinib maleate - Chengdu Zenitar Biomedical Technology

Alternative Names: Flonoltinib; Flonoltinib - Chengdu Zenitar Biomedical Technology; Flunotinib; Flunotinib - Chengdu Zenitar Biomedical Technology

Latest Information Update: 18 Jun 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Chengdu Zenitar Biomedical Technology
  • Class Antineoplastics
  • Mechanism of Action Fms-like tyrosine kinase 3 inhibitors; Janus kinase 2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Myelofibrosis
  • Phase I Myeloproliferative disorders
  • Clinical Phase Unknown COVID 2019 infections
  • Preclinical Haemophagocytic lymphohistiocytosis

Most Recent Events

  • 06 May 2024 Phase-II clinical trials in Myelofibrosis in China (PO) (NCT06457425)
  • 29 Feb 2024 Chengdu Zenitar Biomedical Technology initiates a phase I trial (In volunteers) in China (PO) (NCT06387966)
  • 01 Mar 2023 Chemical structure information added

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top